# CVM GFI #255 Elemental Impurities in Animal Drug Products Questions and Answers - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-255-elemental-impurities-in-animal-drug-products-questions-and-answers/d270daab-b0d8-413c-9870-899b1c8f31af

> FDA guidance document: CVM GFI #255 Elemental Impurities in Animal Drug Products Questions and Answers. Issue date: November 23, 2020. Get complete insights and analysis.

---

## Details

- Title: CVM GFI #255 Elemental Impurities in Animal Drug Products Questions and Answers
- Communication Type: Guidance Document
- Product Type: veterinary
- Office Name: Center for Veterinary Medicine
- Office URL: /offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4
- Issue Date: 2020-11-23
- Comment Close Date: 2018-05-29
- Last Changed: 2021-01-20
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-0943">FDA-2018-D-0943</a>

## Related Documents

- [CVM GFI #267 Biomarkers and Surrogate Endpoints in Clinical Studies to Support Effectiveness of New Animal Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-267-biomarkers-and-surrogate-endpoints-in-clinical-studies-to-support-effectiveness-of-new-animal-drugs/017aa044-c960-4f4a-b6e9-4aed194af7c4)
- [CVM GFI #240 Proprietary Names for New Animal Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-240-proprietary-names-for-new-animal-drugs/f55b2f01-4717-4a80-bb0b-58ef07fd3691)
- [CVM GFI #242 In-Use Stability Studies and Associated Labeling Statements for Multiple-Dose Injectable Animal Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-242-in-use-stability-studies-and-associated-labeling-statements-for-multiple-dose-injectable-animal-drug-products/33ab4dc2-4b4f-44d3-a020-521b35e42bc9)